金域医学 (603882.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(金域医学)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 1,737,946,295.652,039,645,414.861,841,260,736.252,230,005,782.032,001,110,411.402,190,945,442.882,117,566,265.14
 营业收入(元) 1,737,946,295.652,039,645,414.861,841,260,736.252,230,005,782.032,001,110,411.402,190,945,442.882,117,566,265.14
二、营业总成本(元) 1,611,293,307.911,767,197,709.571,739,097,569.902,059,531,199.851,899,083,333.761,855,157,863.051,821,458,551.68
 营业成本(元) 1,111,613,944.951,281,531,265.171,250,450,786.631,477,296,653.181,309,335,078.741,323,258,035.731,314,646,539.73
 研发费用(元) 105,594,922.84104,648,170.4192,123,715.26101,673,125.94111,258,313.12122,564,536.06131,642,934.47
 营业税金及附加(元) 3,737,170.083,763,828.544,087,848.464,199,383.903,804,803.233,308,660.213,599,603.27
 销售费用(元) 224,483,384.72221,830,861.45231,582,425.82277,345,038.00254,075,118.88250,186,920.28233,482,848.88
 管理费用(元) 166,966,804.64154,977,169.25161,165,342.69198,927,888.49219,960,879.67157,184,383.31138,534,152.93
 财务费用(元) -1,102,919.32446,414.75-312,548.9689,110.34649,140.12-1,344,672.54-447,527.60
  其中:利息费用(元) 4,829,381.694,415,376.394,910,179.275,103,124.124,414,367.575,450,043.395,423,305.34
  其中:利息收入(元) 6,279,192.964,808,258.565,799,739.125,583,360.494,408,023.987,762,452.277,634,261.57
 资产减值损失(元) -17,634.54300,928.69-242,874.19-27,509.30255,689.39278,073.5112,793.26
 信用减值损失(元) -124,572,239.37-156,492,352.81-139,495,232.14-96,239,187.29-74,836,369.69-169,727,638.43-147,733,754.71
三、其他经营收益
 加:投资收益(元) -3,301,402.51559,434.52-2,380,675.99812,170.03269,281,171.46-2,513,709.05-4,612,633.19
  其中:对联营企业和合营企业的投资收益(元) -3,301,402.51187,813.96-2,380,675.99-32,282.49-2,655,905.18-2,513,709.05-4,612,633.19
 资产处置收益(元) 684,050.55684,468.863,291,258.061,601,365.46524,697.6481,042.52-6,570.88
 其他收益(元) 8,664,344.179,622,281.6111,643,109.0840,725,517.318,857,864.087,958,956.1120,673,152.86
四、营业利润(元) 8,110,106.04127,122,466.16-25,021,248.83117,346,938.39306,110,130.52171,864,304.49164,440,700.80
 加:营业外收入(元) 485,789.97502,980.08801,067.081,069,413.97874,026.311,226,030.59613,127.15
 减:营业外支出(元) 9,532,112.463,942,167.802,585,760.105,291,582.395,749,494.434,428,768.647,786,282.44
五、利润总额(元) -936,216.45123,683,278.44-26,805,941.85113,124,769.97301,234,662.40168,661,566.44157,267,545.51
 减:所得税费用(元) -1,542,149.2114,001,936.16-386,528.4642,865,948.0316,820,572.2427,042,945.7616,650,567.26
六、净利润(元) 605,932.76109,681,342.28-26,419,413.3970,258,821.94284,414,090.16141,618,620.68140,616,978.25
(一)按经营持续性分类
  持续经营净利润(元) 605,932.76109,681,342.28-26,419,413.3970,258,821.94284,414,090.16141,618,620.68140,616,978.25
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 4,188,788.59108,287,287.70-18,637,084.2267,364,961.55291,173,710.58135,230,269.25149,613,208.46
  少数股东损益(元) -3,582,855.831,394,054.58-7,782,329.172,893,860.39-6,759,620.426,388,351.43-8,996,230.21
 扣除非经常性损益后的净利润(元) 3,761,784.64103,544,188.23-29,294,758.0621,998,010.5269,985,996.77131,970,736.66140,603,895.60
七、每股收益
 一、基本每股收益(元) 0.010.23-0.040.150.620.290.32
 二、稀释每股收益(元) 0.010.23-0.040.150.620.290.32
八、其他综合收益(元) -6,471,050.343,346,308.5980,537.60-7,251,781.361,969,452.2128,143,198.14-14,870,468.81
 归属于母公司股东的其他综合收益(元) -6,471,050.343,346,308.5980,537.60-7,251,781.361,969,452.2128,143,198.14-14,870,468.81
九、综合收益总额(元) -5,865,117.58113,027,650.87-26,338,875.7963,007,040.58286,383,542.37169,761,818.82125,746,509.44
 归属于母公司所有者的综合收益总额(元) -2,282,261.75111,633,596.29-18,556,546.6260,113,180.19293,143,162.79163,373,467.39134,742,739.65
 归属于少数股东的综合收益总额(元) -3,582,855.831,394,054.58-7,782,329.172,893,860.39-6,759,620.426,388,351.43-8,996,230.21
公告日期 2024-10-312024-08-312024-04-262024-04-262023-10-282023-08-292023-04-25
审计意见(境内) 标准无保留意见

前瞻产业研究院